Alkem Laboratories has informed that as part of the Company’s operational strategy, the operations of the Company carried out at the St. Louis manufacturing facility situated in USA owned by S&B Pharma LLC, a step-down subsidiary of the Company, (Facility) are closed. Accordingly, all rights, title and interest in the land, improvements and personal property with respect to the said Facility owned by S&B Pharma LLC, a step-down subsidiary of the Company in USA (Seller) are sold to New Mill Capital Holdings LLC (Buyer) pursuant to the ‘Purchase and Sale Agreement’ executed between the Buyer and Seller. The details as required under SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 are enclosed as Annexure I.
The above information is a part of company’s filings submitted to BSE.